Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
July 30 2019 - 6:04AM
Edgar (US Regulatory)
Filed by Exact Sciences Corporation
pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
under the Securities Exchange Act of 1934
Filer: Exact Sciences Corporation
Subject Company: Genomic Health, Inc.
SEC File No.: 000-51541
Date: July 29, 2019
The following is available at www.leadingcancerdiagnostics.com:
19-15265-10 C1.1 P2
JULY 29,2019 EXACT SCIENCES AND GENOMIC HEALTH TO COMBINE, CREATING LEADING GLOBAL CANCER DIAGNOSTICS COMPANY PRESS RELEASE 19-15265-10C1.1P3
JULY 29,2019 EXACT SCIENCES TO COMBINE WITH GENOMIC HEALTH LISTEN TO WEBCAST DOWNLOAD INVESTOR PRESENTATION DOWNLOAD INFOGRAPHIC 19-15265-10C1.1P4
EXACT SCIENCES FILINGS GENOMIC HEALTH FILINGS 19-15265-10C1.1P5
* * *
Genomic Health (NASDAQ:GHDX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Genomic Health (NASDAQ:GHDX)
Historical Stock Chart
From Sep 2023 to Sep 2024